Armata Pharmaceuticals (ARMP) Other Non-Current Assets (2013 - 2026)

Armata Pharmaceuticals (ARMP) has 11 years of Other Non-Current Assets data on file, last reported at $813000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets fell 84.92% year-over-year to $813000.0; the trailing twelve-month figure through Mar 2026 stood at $813000.0 (down 84.92% YoY), and the FY2025 full-year result was $5.4 million, down 1.64% from the prior year.
• Other Non-Current Assets fell to $813000.0 in Q1 2026, from $5.4 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $6.0 million in Q1 2022 to a low of $813000.0 in Q1 2026.
• A 5-year average of $5.1 million and a median of $5.5 million in 2024 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets surged 396.67% in 2022 and tumbled 84.92% in 2026, its largest moves.
• Tracing ARMP's Other Non-Current Assets over 5 years: stood at $6.0 million in 2022, then declined by 4.03% to $5.7 million in 2023, then slipped by 4.2% to $5.5 million in 2024, then dropped by 1.64% to $5.4 million in 2025, then plunged by 84.92% to $813000.0 in 2026.
• Business Quant data shows ARMP's Other Non-Current Assets at $813000.0 in Q1 2026, $5.4 million in Q4 2025, and $973000.0 in Q3 2025.